Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00955396 · ClinicalTrials.gov registry record · Phase 1
Study to Investigate the Effect of GSK1014802 on Ambulatory Blood Pressure
A Phase 1 study, sponsored by Biogen.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT00955396 is a Phase 1 study that has completed, run by Biogen. The registered enrollment target is 60 participants.
The verdict
NCT00955396, a Phase 1 study, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
In this study the investigators will determine whether there is any effect of GSK1014802 on ambulatory blood pressure. This will be a randomized, double-blind, placebo-controlled, repeat dose, 2 period cross-over study conducted in healthy male and female subjects. Approximately 60 subjects will be randomised to receive GSK1014802 400 mg bid and placebo for 36 days with at least 1 week between treatment sessions. A follow-up will occur 7-14 days after the last dose.
Interventions
- DRUG Placebo
- DRUG GSK1014802
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-07-31 |
| Est. Completion | 2009-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00955396
The ClinicalTrials.gov registry entry for NCT00955396 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00955396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00955396 about?
NCT00955396 is a clinical study titled "Study to Investigate the Effect of GSK1014802 on Ambulatory Blood Pressure". In this study the investigators will determine whether there is any effect of GSK1014802 on ambulatory blood pressure. This will be a randomized, double-blind, placebo-controlled, repeat dose, 2 period cross-over study conducted in healthy male and female subjects. Approximately 60 subjects will be ...
What is the current status of trial NCT00955396?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2009-07-31. Estimated completion is 2009-12-31.
What interventions are being tested in trial NCT00955396?
The interventions under investigation include: Placebo (DRUG), GSK1014802 (DRUG).
Who is sponsoring clinical trial NCT00955396?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.